1. Home
  2. UNFI vs SRPT Comparison

UNFI vs SRPT Comparison

Compare UNFI & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United Natural Foods Inc.

UNFI

United Natural Foods Inc.

N/A

Current Price

$45.98

Market Cap

2.4B

ML Signal

N/A

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

N/A

Current Price

$20.09

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UNFI
SRPT
Founded
1976
1980
Country
United States
United States
Employees
25600
N/A
Industry
Food Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.5B
IPO Year
1996
2000

Fundamental Metrics

Financial Performance
Metric
UNFI
SRPT
Price
$45.98
$20.09
Analyst Decision
Hold
Hold
Analyst Count
7
28
Target Price
$44.71
$25.40
AVG Volume (30 Days)
754.7K
3.2M
Earning Date
03-10-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.25
N/A
Revenue
N/A
$2,198,237,000.00
Revenue This Year
$0.46
N/A
Revenue Next Year
$2.18
N/A
P/E Ratio
$183.88
N/A
Revenue Growth
N/A
15.58
52 Week Low
$21.27
$10.42
52 Week High
$47.59
$65.69

Technical Indicators

Market Signals
Indicator
UNFI
SRPT
Relative Strength Index (RSI) 66.09 56.96
Support Level $35.20 $16.38
Resistance Level N/A $23.01
Average True Range (ATR) 1.60 1.19
MACD 0.59 0.54
Stochastic Oscillator 70.86 51.65

Price Performance

Historical Comparison
UNFI
SRPT

About UNFI United Natural Foods Inc.

United Natural Foods Inc is a wholesale distributor of natural, organic and specialty foods and nonfood products across North America. The company's products consist of national, regional and private label brands grouped into grocery and general merchandise, produce, perishables and frozen foods, nutritional supplements and sports nutrition, bulk and foodservice products, and personal care items. United Natural Foods serves various retail formats including conventional supermarket chains, natural product superstores, independent retail operators and foodservice channels such as e-commerce platforms. The company's operations are comprised of principal divisions: the wholesale division; the retail division; and other.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: